News

Brief news reports on Tuberculosis

Uganda: New TB treatment in relation to HIV

The world conference on TB and chest health opened in full gear in Lille France, with a keynote presentation by the executive director of the Global Fund to fight AIDS, TB and Malaria, Prof Michel D Kazatchkine.

Read More →

Technology delivers live TB detection results in a revolutionary time of 4 days

NanoLogix, an innovator in the rapid detection, identification and antibiotic sensitivity determination of live bacteria announced today third-party results for detecting live Mycobacterium tuberculosis (TB) in a revolutionary time of 4 days with its BNP (BioNanoPore) technology. The advanced culture test results with the NanoLogix BNP technology are at least 500% faster than the 21-day standard for live TB culture detection. Additionally, other test methods for tuberculosis are expensive, labor intensive and cannot determine if a microbe found in a sample is living or dead. The NanoLogix technology provides a significant advantage over conventional methods for detecting TB in developing regions where medical resources are scarce and TB infections are rampant.

Read More →

TB Partnerships: Whole is greater than the sum of its parts

A report released online earlier this week states that effective partnerships can improve tuberculosis responses globally. The summary report, titled, "Whole Is Greater Than The Sum Of Its Parts", was also distributed at the 42nd Union World Conference on Lung Health in Lille, France. This report is the summary of the online consultation that was facilitated by CNS: www.citizen-news.org – a partner of the Stop TB Partnership - using social media platforms and  also the Stop-TB eForum that was established by the Health and Development Networks (HDN) in early 2001, and currently is supported by the Stop TB Partnership, the International Union Against Tuberculosis and Lung Disease (The Union) and the International HIV/AIDS Alliance, and managed by CNS. The online consultation was held during October 2011.

Read More →

Steps toward integrated TB/HIV advocacy in Kenya

Evelyne Kibuchi is a senior tuberculosis (TB) advocacy officer at the Kenya AIDS NGOs Consortium (KANCO), a national umbrella organization of civil society groups in Kenya that collaborate for resource mobilization for TB and HIV.

Read More →

Scaling up partnership for TB/HIV integration in the vertical health care system in Ukraine

Zaheld Islam of the International HIV/AIDS Alliance in the Ukraine shared his organization’s work on TB/HIV integration at a Saturday session of the Union World Conference on Lung Health in France. The Alliance is a Global Fund to Fight AIDS, Tuberculosis and Malaria sub-grantee in the Ukraine with resources from both TB and HIV grants. They also receive resources from the U.S. Agency for International Development (USAID) and UNAIDS.

Read More →

ZAMSTAR project reduces prevalence of tuberculosis by 22%

The results of a large-scale community-randomized trial, which were presented at the 42nd World Conference on Lung Health in Lille, France show that the Zambia South Africa TB and AIDS Reduction (ZAMSTAR) study's "Household Counselling" intervention reduced the prevalence of culture positive tuberculosis by 22% compared to the communities that did not receive the intervention.

Read More →

Straight talk with Stop TB Director Mario Raviglione

With global health funding on the decline, officials are concerned that strains of tuberculosis (TB), including multi-drug resistant tuberculosis (MDR-TB), may go untreated. Stop TB Director Mario Raviglione spoke to IRIN/PlusNews at the International Lung Health Conference in Lille, France, about the threat of drug resistant TB treatment and the precarious TB funding gap.

Read More →

TapImmune Inc. and Aeras start research & development collaboration

TapImmune Inc. announced that it has signed a Research Collaboration with Aeras. The overall goal of this collaboration will be to evaluate the efficacy of TAP in concert with novel vaccine vectors encoding TB immunogens under development at Aeras with the aim of advancing suitable candidates to clinical development. Aeras will conduct all pre-clinical development studies at their laboratories in Rockville, MD.  

Read More →

Indonesia: Injecting drug use a major risk factor for HIV-associated TB

A study in Indonesia has found that people with HIV who injected drugs were 85% more likely to have HIV-associated tuberculosis than those who were not injecting drug users. The findings were presented at the 42nd Union World Lung Health Conference held in Lille, France, last week.

Read More →

Out of the Dark: An implementers’ guide to managing TB in children

This report outlines the current state of paediatric TB care, looking at current practices, new developments and research needs – in paediatric TB diagnosis, treatment and prevention.

Read More →

Page 546 of 563 · Total posts: 10

←First 545 546 547 Last→